Back
Lyell Immunopharma Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
38
LYEL
Lyell Immunopharma
Last Price:
1.23
Seasonality Move:
-24.64%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Lyell Immunopharma Price Quote
$1.23
-0.05 (-3.91%)
(Updated: November 5, 2024 at 11:25 AM ET)
Lyell Immunopharma Key Stats
Sell
38
Lyell Immunopharma (LYEL)
is a Sell
Day range:
$1.05 - $1.31
52-week range:
$0.85 - $3.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6,007.52
P/B ratio:
0.58%
Volume:
1.9M
Avg. volume:
1.4M
1-year change:
-40.19%
Market cap:
$327.7M
Revenue:
$130K
EPS:
$-0.82
How Much Does Lyell Immunopharma Make?
-
How Much Are Lyell Immunopharma's Sales Annually?
LYEL Revenues are $130K -
How Much Profit Does Lyell Immunopharma's Make A Year?
LYEL net income is -$234.6M
Is Lyell Immunopharma Growing As A Company?
-
What Is Lyell Immunopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.52% -
What Is Lyell Immunopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Lyell Immunopharma Stock Price Performance
-
Did Lyell Immunopharma Stock Go Up Last Month?
Lyell Immunopharma share price went up by 4.92% last month -
Did LYEL's Share Price Rise Over The Last Year?
LYEL share price fell by -40.19% over the past 1 year
What Is Lyell Immunopharma 52-Week High & Low?
-
What Is Lyell Immunopharma’s 52-Week High Share Price?
Lyell Immunopharma has traded as high as $3.26 over the past 52 weeks -
What Is Lyell Immunopharma’s 52-Week Low Share Price?
Lyell Immunopharma has traded as low as $0.85 over the past 52 weeks
Lyell Immunopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lyell Immunopharma?
-
How Much Debt Does Lyell Immunopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Lyell Immunopharma Have?
Cash and short term investments quarterly total is $491.1M -
What Is Lyell Immunopharma’s Book Value Per Share?
Book value per share is 2.21
Is Lyell Immunopharma Cash Flow Positive?
-
What Is LYEL Cash Flow From Operations?
Cash flow from operations (TTM) is -$158.4M -
What Is Lyell Immunopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.5M -
What Is Lyell Immunopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $66M
Lyell Immunopharma Return On Invested Capital
-
Is Management Doing A Good Job?
LYEL return on invested capital is -32.26% -
What Is Lyell Immunopharma Return On Assets?
ROA measures how assets are converting to revenues and is -28.19% -
What Is LYEL Return On Equity?
ROE is a measure of profitability and is -32.26%
Lyell Immunopharma Earnings Date & Stock Price
-
What Is Lyell Immunopharma's Stock Price Today?
A single share of LYEL can be purchased today for 1.28 -
What Is Lyell Immunopharma’s Stock Symbol?
Lyell Immunopharma trades on the nasdaq under the ticker symbol: LYEL -
When Is Lyell Immunopharma’s Next Earnings Date?
The next quarterly earnings date for Lyell Immunopharma is scheduled on November 7, 2024 -
When Is LYEL's next ex-dividend date?
Lyell Immunopharma's next ex-dividend date is November 5, 2024 -
How To Buy Lyell Immunopharma Stock?
You can buy Lyell Immunopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lyell Immunopharma Competitors
-
Who Are Lyell Immunopharma's Competitors?
Below is a list of companies who compete with Lyell Immunopharma or are related in some way:
Lyell Immunopharma Dividend Yield
-
What Is LYEL Dividend Yield?
Lyell Immunopharma’s dividend yield currently is 0% -
What Is Lyell Immunopharma’s Payout Ratio?
Lyell Immunopharma’s payout ratio is 0% -
When Did Lyell Immunopharma Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Lyell Immunopharma’s Dividend Per Share?
Lyell Immunopharma pays a dividend of $0.00 per share
Lyell Immunopharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -51.85% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 2.50 |
| Upside from Last Price: | 95.31% |